Literature DB >> 23317073

Iron deficiency anemia: evaluation and management.

Matthew W Short1, Jason E Domagalski.   

Abstract

Iron deficiency is the most common nutritional disorder worldwide and accounts for approximately one-half of anemia cases. The diagnosis of iron deficiency anemia is confirmed by the findings of low iron stores and a hemoglobin level two standard deviations below normal. Women should be screened during pregnancy, and children screened at one year of age. Supplemental iron may be given initially, followed by further workup if the patient is not responsive to therapy. Men and postmenopausal women should not be screened, but should be evaluated with gastrointestinal endoscopy if diagnosed with iron deficiency anemia. The underlying cause should be treated, and oral iron therapy can be initiated to replenish iron stores. Parenteral therapy may be used in patients who cannot tolerate or absorb oral preparations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23317073

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  39 in total

1.  Status of Iron Metabolism 10 Years After Roux-En-Y Gastric Bypass.

Authors:  Daniela Vicinansa Monaco-Ferreira; Vânia Aparecida Leandro-Merhi
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

2.  Prenatal manganese and cord blood mitochondrial DNA copy number: Effect modification by maternal anemic status.

Authors:  Allison Kupsco; Marco Sanchez-Guerra; Chitra Amarasiriwardena; Kasey J M Brennan; Guadalupe Estrada-Gutierrez; Katherine Svensson; Lourdes Schnaas; Ivan Pantic; Martha María Téllez-Rojo; Andrea A Baccarelli; Robert O Wright
Journal:  Environ Int       Date:  2019-03-05       Impact factor: 9.621

3.  Consensus Statement by an Expert Panel on the Diagnosis and Management of Iron Deficiency Anemia in the Gulf Cooperation Council Countries.

Authors:  Aamer Aleem; Faisal Alsayegh; Satish Keshav; Abdulrahman Alfadda; Ahmad Awad Alfadhli; Abdulrahman Al-Jebreen; Fawaz Al-Kasim; Ali Almuhaini; Hazzaa Al-Zahrani; Faisal Batwa; Srdjan Denic; Ahmad Jazzar; Tarek Owaidah; Mohamad Qari; Yousef Qari; Mazen Taha
Journal:  Med Princ Pract       Date:  2019-11-05       Impact factor: 1.927

4.  Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.

Authors:  Amina Delpeuch; Marc Ruivard; Armand Abergel; Olivier Aumaitre; Stéphane Boisgard; Sandrine Bagel; Valérie Sautou
Journal:  Int J Clin Pharm       Date:  2018-03-08

5.  Renal functional and structural integrity in infants with iron deficiency anemia: relation to oxidative stress and response to iron therapy.

Authors:  Mohamed S El-Shimi; Rania A El-Farrash; Eman A Ismail; Ibrahim A El-Safty; A El-Safty; Ahmed S Nada; Omayma A El-Gamel; Yomna M Salem; Sara M Shoukry
Journal:  Pediatr Nephrol       Date:  2015-05-16       Impact factor: 3.714

6.  Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.

Authors:  Hiroshi Kawabata; Takeshi Tamura; Soichiro Tamai; Akiko Fujibayashi; Motoi Sugimura
Journal:  Int J Hematol       Date:  2022-07-06       Impact factor: 2.319

Review 7.  The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease.

Authors:  Pramoda Koduru; Bincy P Abraham
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 8.  Emerging point-of-care technologies for anemia detection.

Authors:  Ran An; Yuning Huang; Yuncheng Man; Russell W Valentine; Erdem Kucukal; Utku Goreke; Zoe Sekyonda; Connie Piccone; Amma Owusu-Ansah; Sanjay Ahuja; Jane A Little; Umut A Gurkan
Journal:  Lab Chip       Date:  2021-05-18       Impact factor: 6.799

9.  Patient Factors Associated with Prescribing of Iron for IV Administration: A Descriptive Study.

Authors:  Thomas Brownlee; Deonne Dersch-Mills; Ginny Cummings; Tanya Fischer; Rhonda Shkrobot; Jeremy Slobodan; Jenny Wichart
Journal:  Can J Hosp Pharm       Date:  2021-01-01

10.  Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.

Authors:  Nobuyuki Matsumoto; Hiroki Ikeda; Ryuta Shigefuku; Nobuhiro Hattori; Tsunamasa Watanabe; Kotaro Matsunaga; Tetsuya Hiraishi; Tomohiro Tamura; Yohei Noguchi; Yasunobu Fukuda; Toshiya Ishii; Chiaki Okuse; Akira Sato; Michihiro Suzuki; Fumio Itoh
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.